Levi & Korsinsky home
    • New Cases
    • Investigation
    • About Us
    • Attorneys
    • FAQ
    • Company Research
    • Recent SEC Filings
  • News
  • Insights
  • Learn
    • New Cases
    • Investigation
    • About Us
    • Attorneys
    • FAQ
    • Company Research
    • Recent SEC Filings
  • News
  • Insights
  • Learn
  1. Home >
  2. Tickers >
  3. YEWB >
  4. SEC Filings
YEWB

Yew Bio-Pharm Group, Inc. SEC Filings

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

SEC Filings

8-K

Current report, filed Mar 29, 2022

2022-03-29

DEF 14C

Other definitive information statements, filed Nov 29, 2021

2021-11-29

DEFA14C

Additional information statement materials, definitive, filed Nov 29, 2021

2021-11-29

PRE 14C

Other preliminary information statements, filed Nov 15, 2021

2021-11-15

10-K

Annual report, filed Mar 30, 2021

2021-03-30

8-K

Current report, filed Jan 05, 2021

2021-01-05

8-K

Current report, filed Sep 15, 2020

2020-09-15

8-K

Current report, filed May 15, 2020

2020-05-15

8-K

Current report, filed May 06, 2020

2020-05-06

8-K

Current report, filed Mar 30, 2020

2020-03-30

Email
[email protected]

Phone
212-363-7500

Address
33 Whitehall Street, 27th Floor
New York, NY 10004

    • Active Cases
    • Investigation
    • About Us
    • Attorneys
    • FAQ
    • Company Research
    • Recent Filings
  • News
  • Insights
  • Learn
Levi & Korsinsky, LLP

© 2026 Levi & Korsinsky, LLP
Attorney Advertising. The information on this website and its content is for general information purposes only and does not constitute legal advice. Prior results do not guarantee a similar outcome.

Hey AI, learn about us

  • Terms and Conditions
  • Privacy Policy